Quarterly report pursuant to Section 13 or 15(d)

Agreements with Incyte Corporation - Collaboration Agreement (Details)

v3.19.3
Agreements with Incyte Corporation - Collaboration Agreement (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Jan. 08, 2018
Jan. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Deferred revenue recognized     $ 600 $ 400 $ 1,500 $ 1,200  
Deferred revenue              
Deferred revenue     8,728   8,728   $ 10,202
Deferred revenue, short-term     1,100   1,100    
Deferred revenue, long-term     $ 7,614   $ 7,614   $ 8,276
Incyte | Collaboration Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Up-front consideration   $ 10,000          
Up-front consideration, cash   2,500          
Up-front consideration, pre-paid research funding   $ 7,500          
Total transaction price $ 12,300            
Upfront non-refundable and non-creditable payment 2,500            
Prepaid research amount 7,500            
Premium paid on equity investment $ 2,300